CorMedix (CRMD) Capital Expenditures (QoQ) (2015 - 2025)
CorMedix (CRMD) Capital Expenditures (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 240.09% |
| Sep 30, 2025 | 2,012.23% |
| Jun 30, 2025 | 135.29% |
| Mar 31, 2025 | 0.37% |
| Dec 31, 2024 | 3.82% |
| Sep 30, 2024 | -71.93% |
| Jun 30, 2024 | -43.25% |
| Mar 31, 2024 | -79.28% |
| Dec 31, 2023 | 2,788.54% |
| Sep 30, 2023 | 61.14% |
| Jun 30, 2023 | -56.94% |
| Mar 31, 2023 | -88.53% |
| Dec 31, 2022 | 68.49% |
| Sep 30, 2022 | 674.79% |
| Jun 30, 2022 | 128.10% |
| Mar 31, 2022 | -99.31% |
| Dec 31, 2021 | -19.17% |
| Sep 30, 2021 | 13,746.03% |
| Jun 30, 2021 | -57.05% |
| Mar 31, 2021 | -83.03% |